Search - tctmd.com

Displaying 621 - 640 of 747

Sort: Relevancy | Date

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

Presentation

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

Presenter: G. Sarno

January 08, 2012

News Daily News

Carotid Stenting, Endarterectomy Both Reasonable After Cervical Irradiation

January 05, 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

The Difference of Predictors for Occurrence of Instent Restenosis in the under-expanded or non under-expanded post-DES implantation : An intravascular ultrasound analysis...

Presentation TCT 2012

The Difference of Predictors for Occurrence of Instent Restenosis in the under-expanded or non under-expanded post-DES implantation : An intravascular ultrasound analysis...

Presenter: Ki-Woon Kang, Byeong-Keuk Kim, Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 03, 2012

Noninvasive Assessment of In-Stent Restenosis by High Definition Computed Tomography Coronary Angiography with New Gemstone Detector

Presentation TCT 2012

Noninvasive Assessment of In-Stent Restenosis by High Definition Computed Tomography Coronary Angiography with New Gemstone Detector

Presenter: Hirotsugu Mihara

January 03, 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presentation TCT 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presenter: Didier Carri?, Nicolas Delarche, Christophe Piot, Jacques Berland, Nicolas Meneveau, Laurent Benello, Antoine Py, Emmanuel Teiger, Laurent Leborgne, Gilles Bayet, Olivier Wittenberg

January 03, 2012

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Presentation TCT 2012

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Effects of Low Dose Pioglitazone on Restenosis and Atheroma Plaques in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Presentation TCT 2012

Effects of Low Dose Pioglitazone on Restenosis and Atheroma Plaques in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Presenter: Sung Gyu An, Mi in Yang, Hye won Lee, Jun hyok Oh, Jung hyun Choi, Han cheol Lee, Kwang soo Cha, Taek jong Hong

January 03, 2012

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Presentation TCT 2012

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Presenter: Torsten Schwalm, J?rg Carlsson, Bo Lagerqvist, Stefan James

January 03, 2012

Comparison of Virtual Histology and OCT in the Tissue Characterization of In-Stent Restenosis.

Presentation TCT 2012

Comparison of Virtual Histology and OCT in the Tissue Characterization of In-Stent Restenosis.

Presenter: Koichi Hanada, Akihiro Nakamura

January 03, 2012

Bioadhesive, Drug Impregnated Thin Films for Vascular Restenosis Treatment.

Presentation TCT 2012

Bioadhesive, Drug Impregnated Thin Films for Vascular Restenosis Treatment.

Presenter: Terry W. Steele, Joachim S. Loo, Subbu S. Venkatraman

January 03, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Daily News

CAS Plus Cardiac Surgery a Promising Option for Symptomatic Patients

Yael L. Maxwell

December 07, 2011

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.